ORDI to raise fund for rare disease patients via Race for 7
Mumbai: In a move to unroll awareness for rare disease, which is not so rare, the Organization for Rare Diseases India (ORDI) has announced ‘Race for 7’, a multi-city run/walk to raise funds for rare disease patients in India.
The Race for 7, figuratively represents 7000 rare disease with 7000 people running for 7 kilometres to represent the average number of years it takes to diagnose a rare disease.
An estimated 1 in 20 Indians suffers from a rare disease, however, lack of awareness and information has created several challenges for patients and their caregivers, most importantly delayed diagnosis, affordable and targeted care and treatment and access.
The run will be organized in Mumbai on February 24, by the not for profit organization, ORDI. The Race for 7 is held in the month of February to commemorate World Rare Disease Day which falls on the last day of February.
Besides members of the general public, several rare disease patients and their families will participate in Race for 7 to draw attention to the challenges they face and the need for governments and other institutions to recognize their unique needs and create enabling policies and a more supportive environment for them.
The theme for Rare Disease Day 2019 is ‘Bridging health and social care’, focusing on the need to better coordinate all aspects of care to improve the lives of people living with a rare disease.
What started as an awareness walk to commemorate World Rare Disease Day in February 2016 has now grown into a significant campaign, conducted simultaneously in multiple cities and two countries – India and the USA.
Over the years, the run has expanded and in 2019 it will be conducted over February and March across 10 Indian cities – Bengaluru, Mysuru, Chennai, Kolkata, Mumbai, Jaipur, Coimbatore, Bikaner, New Delhi, Thiruvananthapuram, Kochi.
Commenting on the Race, Prasanna Shirol, Founder Director, ORDI, and father of a rare disease patient, says, “One in every 20 Indians suffers from a rare disease almost half of whom are children, an important fact that often doesn’t get highlighted. Besides, lack of access to early intervention and treatment because of the lack of widespread awareness about rare diseases, the cost of treatment where available is often prohibitively expensive.”
“We urgently need national and state policies that address the unique requirements of the rare disease community and enable them to lead lives of dignity and self-worth. We also need institutions like corporates and schools and colleges to create a more inclusive environment for rare disease patients,” he added.
Rare Diseases is a key therapeutic focus for IQVIA who has provided clinical services for more than 258 rare disease studies in 87 countries worldwide since 2011.
“IQVIA is delighted to be associated for the fourth consecutive year as the main sponsor of Race for 7, an event that has been growing in stature and impact. While rare diseases, by virtue of their definition, affect relatively fewer number of patients, the overall number of rare disease patients is large enough to warrant more focused attention. We hope that the public will come forward in large numbers to participate in Race for 7 and help amplify the voice of the rare disease community. The Race for 7 is a unique way of engaging the community with those who matter most –patients and their caregivers - for a common cause,” said Amit Mookim, Managing Director, IQVIA – South Asia.
Also Read: NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report
Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd